Science as Social Enterprise - Thoughts from Richard Jefferson and Cambia on democratizing science-enabled innovation - page 2

Reinventing Wheels: How biological open source licensing works.

Almost all technologies in the life sciences are intertwined and interdependent. Few discoveries stand on their own, and fewer inventions. Not only do they each depend on the pre-existing knowledge base, they almost always incorporate components of many other technologies in their execution.

This is particularly true for tools and technologies that are what I call ‘meta-technologies’, whose effects are broad and that are useful for communities of innovators who are quite distant from the inventor of the tool.

Consider the wheel. It is clearly a tool, and clearly a meta- technology. In some ways, it is the most fundamental and important tool in society, as it has so many uses, unanticipated by its inventor(s). These uses are countless, and they are mostly made by people who are not wheel-builders.


Neglected Diseased: Telomerase, Cancer, Patents and Poverty

With the welcome attention to ‘neglected diseases’ such as malaria and tuberculosis associated with poverty, there is a tendency to forget the many health challenges such as heart disease, diabetes and cancer which wreak havoc in both worlds. These ‘shared diseases’ have dramatically different markets in both first and third world, and some thoughts about the disparity in options exposes some structural failings and innovation opportunities.

Leaving the development of diagnostics and treatments of such diseases and conditions to market forces, especially when intellectual property can be used to control entry of new players, will continue to render these debilitating but familiar illnesses a sad litany of social inequities. Are there ways that research-intensive solutions can be cooperatively generated that can grapple with this challenge?

More of the world dies of cancer than almost any other single disease. According to the WHO, cancer kills almostCancer Incidence and Mortality seven million people a year of whom about half are in the developing world. By comparison, AIDS-related conditions kill about three million people a year.

In the industrialized world, the availability of diagnostics and therapeutics for cancer, while often outrageously expensive, can lead to very favorable outcomes. In the poorer parts of the world, diagnostic technology, when available, is inadequate to the task, and few therapeutics are affordable. There are literally millions of people who die of cancer each year in the poorer parts of the world, many of whom could have had longer and more productive lives if the diagnostic and therapeutic options available to their rich neighbors were available to them.

With cancer, it is not the disease that is neglected, but the diseased.

Telomerase is an enzyme in human cells which repairs the ends of chromosomes, and is tightly regulated in normal and normally aging cells. However in tumor cells and tissues, telomerase is often wildly de-regulated, rendering such cells virtually immortal. As such, it has been viewed as the platform from which a key ‘silver bullet’ for cancer therapeutics, for diagnostics, for gerontology, even for production of stem cells, could evolve.

This was the focus of a fascinating press piece by Judy Foreman in 2003 called “Telomerase: a promising cancer drug stuck in patent hell?


World Congress of Science Journalists

In two weeks – April 19th – I’ll be at another conference in Melbourne, the World Congress of Science Journalists. At that congress, I’ll be producing a session about who benefits from science in a world where virtually every scientific discovery and platform is patented, and the elephant in the room: capability to use science. Phil Campbell, the editor of Nature (the magazine, not the phenomenon) will participate and we hope to expose the journalists to the realities of what’s happened as science becomes fragmented and owned. Few understand the world of patents, fewer still appreciate the profound impacts on our society.


Mapmakers & mariners, shipwrights & sailors

I made a presentation at the A2K meeting last year called Mapmakers and Mariners, Shipwrights and Sailors. I had prepared it while sitting on the stage listening to the other speakers (my preferred mode of preparation). it was inspired by a conversation I had with a fine journalist named Kenn Cukier.

In that discussion we were exploring the parallels between the intense competition to navigate the oceans during the creation of the European mercantile empires of the 1400-1800s, and the ability to navigatekenn-cukier.jpg the patent world now in the new millennium. In both cases, the proprietary knowledge of the routes, the shoals, the dangers, the currents and the ports was of enormous importance for achieving commercial advantage, and of course economic primacy.

Kenn later went on to write an exceptional piece for Nature Biotechnology about navigating patents in biotechnology, further exploring this metaphor.   In the late 1600’s, the Spanish could risk the Manila Galleon traveling from the far East to Spain via the Pacific Ocean – and many of the annual Galleons sunk – because the reward was so high. The profits on silk, silver and spices were astronomical. Navigation and seamanship would have to be exquisitely well developed to justify smaller profits; simply to drop the risk profile. And indeed over the years, as both cartography and maritime technology improved, so did the volume, quality and reciprocity of trade. And of course it was the tools development that drove the navigational capability: the marine sextant allowed latitude to be calculated, the marine chronometer, the longitude.

It is clear that the ability to see the dangers and opportunities, the detritus and the value within the patent system was going to be critical if science and technology is to achieve a greater social good, especially for small markets or weak market signals – one way to say ‘for the benefit of poor people’.


Not Access to Knowledge, but Capability to Use Knowledge!

I attended a meeting called A2K (Access To Knowledge) held at Yale last year (Conference Wiki).   I got to hang with some friends whom I admire, like Yochai Benkler (one of the organizers) and to get to know some remarkable people, like Shay David – a clear and articulate thinker who has since visited us in Canberra.

For all the quality at the meeting, I was somewhat disappointed that there was an exclusive focus on ‘making information available’, but no one was talking about the Elephant in the Room, namely the extraordinary restrictions that were developing on the ‘capability to make use of that information’.

It shouldn’t have been surprising I suppose, for a group of academics – for indeed it was pretty much all academics save perhaps me and the janitor – to not be worried about constraints to the creation of tangible economic value – the core of innovation, as it is generally outside of their purview. But it was nonetheless greatly unsettling. I find the simple thought experiment that comes from testing hypotheses in physics to be a useful exercise.

If you’re proposing a course of action, it is instructive to imagine it succeeding (testing the hypothesis at the limit cases), and asking what consequences would eventuate. In the case of universal access to information, let’s imagine all information is available to everyone, everywhere, at no cost. What then?

Well, ultimately there is no impact of that information on our lives until it is ‘converted’ into products or processes. And the ability to ‘convert’ knowledge, what I call the ‘capability to use knowledge’ is associated with barriers, the most prominent one these days being patents. Thus, if you control by patent (or other means) the permissive use of a process of actually making a drug based on some scientific information; or making a crop based on rice genome information; or making a diagnostic for cancer based on clinical data, then you have effectly co-opted and obtained exclusive control over the value of the entire supporting body of ‘public’ information. So that ‘public information’ only there as a publicly funded (or publicly sanctioned) subsidy of the value proposition for those who control its further development into economic outcomes.

Promiscuous patenting: Why does a dog lick himself?

We all know the answer, of course. And it bears on the question of the unpalatable abuse of the patent system. Why do these people do it? Same answer.

I was working with CAMBIA’s Patent Lens team on the forthcoming ‘landscape’ of patents around plant genes, and stumbled on a newly published patent application. It didn’t list the owner / assignee / applicant…just the inventors and their law firm. But I recognized one of the inventors (and the address, near St. Louis, was a giveaway) and a moment’s Googling confirmed it. Imagine my surprise!

Monsanto figures very prominently in the patent landscape, having filed countless wholesale sequence patents either directly or through their proxy companies, like Mendel Biotechnology, covering genes and promoters from rice, Arabidopsis, maize, cotton, soybean and presumably daffodils and snapdragons. But this patent application, US 2007/67865 A1, which had been hidden from view for years really grated (It dates from a US utility application from 2000, before publication was standard, and only published in 2007).

It claims about 463,173 separate annotated plant genes. Actually it claims exactly that many. Oh and it discloses them too, sort of, although the gargantuan file from the USPTO seems somehow corrupt. Matches the practice I guess.


Gordon Conference on Animal Microbe Symbioses: Hologenome Theory of Evolution

After almost 30 years of thinking and occasionally speaking about the hologenome  theory  I’m registered for the Gordon Conference in New Hampshire in June.  I hope I can meet some open minded and thoughtful people with whom to discuss these thoughts.

Since Gordon Conferences operate under what amounts to Chatham House Rule, and communications can’t be quoted (not that I am likely to publish much at this rate) I thought I’d at least post my abstract here in the dusty old blog.

RA Jefferson “Hologenome Theory” Abstract, Gordon Conference on Animal-Microbe Symbiosis, June 21-26 2015


The Hologenome Theory of Evolution: The origins, logic and implications of a ‘cloud genetics’.

Richard A. Jefferson, Professor of Biological Innovation, Queensland University of Technology (QUT), Brisbane, Australia & Cambia, GPO Box 3200, Canberra, Australia

The hologenome theory of evolution developed by Jefferson (1994, 2007) proposes that natural selection occurs at the level of a holobiont, comprising the population of microbial constituents together with a replication-competent macro-apobiont; in essence a populated scaffold. It asserts that the genetic composition of the holobiont comprises the genetic contributions of the micro- and macro-biota in a form called the hologenome and that this ‘hologenotype’ is optimized by natural selection for its performance and persistence over time, but also for its plasticity and responsiveness to change.

The origins of the theory hinge on studies of glucuronide metabolism by diverse vertebrate-associated microbes. The concentration and bio-availability of virtually all the steroid hormones that modulate, regulate or control reproductive performance, mate choice and ontogeny of vertebrates depends on the microbial processing of conjugated intermediaries, including steroid glucuronides. This occurs in microbially-rich complex ecosystems including intestine and surface epithelia, and is mediated by glucuronidases, arylsulfatases, permeases and other enzymes encoded by an extraordinary diversity of microbial constituents, and allows levels of these circulating hormones (and countless other metabolites) to be adjusted by action of a dynamic population of microbes that in turn are intrinsically sampled from and sampling the environment.

The implications from this premise are many, and in many ways, non-trivial. The ability to alter and modulate, amplify and suppress, disseminate and recruit new capabilities as microbially-encoded ‘traits’ means that sampling, sensing and responding to the environment become intrinsic features and emergent capabilities of the holobiont, with mechanisms that can provide rapid, sensitive, nuanced and persistent performance changes. Hologenome theory is essentially probabilistic. The population of microbes associated with the performant microbiome of a holobiont is neither fixed nor necessarily predictable, with the holobiont behaving as an indeterminate, temporally persistent standing wave.

Just as quantum theory (quantum field theory and quantum mechanics) allows a more accurate and generalizable description of physical phenomena at small and large scale both in time and space, so hologenome theory accommodates observations of the ubiquity and function of microbial populations, but also exposes observational and cognitive bias that has hitherto dominated our thinking about evolution and life sciences and their applications to society and the environment. This includes obvious impacts on health and agricultural improvement strategies, but curiously also economics and social institutions. The now classical ‘New Synthesis’ of evolution is by extension, basically a ‘Newtonian’ view of evolution and has fostered a scholarship of symbiosis that focuses on individual interactions rather than probabilistic, synergistic and dynamic populations and the complex and resilient systems these produce.

In this presentation I will review the biochemical and molecular genetic experimental work underlying the articulation of the theory, and describe some of the implications of its probabilistic nature that neither requires nor supports the intellectual construct and memes of ‘host’ and ‘symbiont’.

RA Jefferson (1994) The Hologenome in “’A Decade of PCR: Celebrating 10 Years of Amplification,’ Proceedings of a Symposium” Video released by Cold Spring Harbor Laboratory Press, 1994. ISBN 0-87969- 473-4.

RA Jefferson (2007) “The Hologenome & Hologenomics: a Different lens on evolution” in Science as Social Enterprise.

The Illahee Talk: opening the innovation ecology

A few months ago, I had the opportunity to speak in Portland, Oregon on my thoughts of opening the innovation ecology.   The talk was sponsored by a non-profit,

The talk was introduced by Illahee’s Director, Peter Schoonmaker.   In his  blog post, Peter described his summary of my presentation.

I used the occasion to wax lyrical about the congruence of the hologenome theory of evolution with our work on creating an open and transparent innovation cartography tool.

I tried to find a common thread of ‘biological innovation’ that can guide not only the practical realities of improving health, agriculture, environment and energy, but also the formation of productive and equitable economic and social structures and tools.

The full video of this presentation is available on Vimeo:   Enabling Innovation

The Lens I: What it's all about

Since its inception twenty five years ago, Cambia has had one goal, even a passion:  to ‘democratize’ science-enabled innovation.

After over twenty years of laboratory work in CambiaLabs, creating, distributing and supporting openly available biological enabling technologies to the global research community –  some of which are amongst the most widely used in the field – we hung up our lab coats and put away our pipettes a few years back.

After over ten years of developing, improving and hosting the Patent Lens,  a hugely popular open web resource, we’re soon to be retiring the site per se.

After almost ten years designing, launching and supporting the BIOS Initiative (Biological Innovation for Open Society, aka Biological Open Source), its new ‘open source’ licensing strategies and its online collaboration platform Bioforge, we pretty much stopped about three years ago.  We turned off

So we’re quitting?  We’ve run out of steam?    Is this the inevitable demise of the simplistic, science as social enterprise, sharing paradigm?

No bloody way, mate.

We have worked hard, contributed some and learnt much in these decades.   But progress through scientific method is based on having hypotheses *disproved*, not proved.     In the course of this – with careful design and with some grudging willingness be wrong – one gets closer to a truth.

So, doing all this stuff, we identified a common global, structural and systemic opportunity to change the system.

Biological Open Source won’t work without it.   Bioforge didn’t work without it. The Public Sector works very poorly without it.   Small enterprise desperately needs it.  Big business wastes billions to get it.

The biggest inefficiency in the history of post-enlightenment civilization is now entrenched, ubiquitous and feels inevitable.

And its pretty similar to the development of clergy, with their ecclesiastical literature, liturgy and their choke hold on society for the previous millenium.

Put simply,  we have to completely shift the demographics of problem solving by creating a global, open and dynamic resource for ‘innovation cartography’.

We must make it possible for virtually anyone to understand the landscapes of science, intellectual property, business, regulation and other innovation ‘intelligence’ that is necessary to make creative enterprise a possibility at all levels of society.

Creating and using credible dynamic landscapes showing the What, Who, Which, When, Where and Why of science-enabled innovation,  individuals and institutions in public and private sector can envision trajectories, partnerships, strategies, risks and opportunities.   We can engage untapped social, financial and intellectual capital to solve real and compelling problems.

These may be food, health, environment, energy or virtually any other productive economic activity.

The Lens

It would have been unthinkably hard ten years ago.  Five years ago, untenable and outrageously expensive.

Now, its manageable, affordable.  And essential.

The next posts will be about the ‘how’.

But it will *start* with  the world’s patents as the entry point to innovation intelligence.


van Linschoten: WikiLeaks WritLarge


Jan Huygens van Linschoten

The world’s greatest disruptive act of  Open Access Publishing.

The Dutch are pragmatists.   If there’s a more practical, hard-nosed, outcome-oriented culture that is steeped in business and trade, it might be the Chinese.  But the Dutch are (in so many ways) giants in the history of trade and commerce.

So it may be surprising that what is arguably history’s most disruptive act of creating a ‘commons of knowledge’ that opened up global trade to competition and fair-play came from a Dutchman,   Jan Huygens van Linschoten.

van Linschoten managed in a single act of sharing – in his case the pilfered Portuguese portolans and charts – to open the world of maritime commerce up to free and open competition, stimulating an era of growth and innovation in technology – shipbuilding, sailing, logistics, cartography and navigation – and in business – insurance, investment tools, financial instruments – that changed civilization for ever.

In 1596 or thereabouts, van Linschoten published what had for over a century and a half, the state secrets of Portugal – the maritime cartography of the Indies – West and East.